NetworkNewsBreaks

TuesdayOct 31, 2023 12:07 pm

NetworkNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Acquires Research Assets to Accelerate PAX-101 NDA Submission

PaxMedica (NASDAQ: PXMD), a pioneering biopharmaceutical company specializing in cutting-edge treatments for neurological disorders, today announced the successful acquisition of certain suramin research assets from Rediscovery Life Sciences (“RLS”). The assets were previously dedicated to the study of suramin’s potential efficacy in treating acute kidney injury resulting from chronic kidney disease. According to the announcement, the newly acquired data from RLS will play a crucial role in bolstering PaxMedica’s ongoing efforts to support the submission for the approval of PAX-101, specifically for the treatment of African sleeping sickness caused by the Trypanosoma brucei rhodesiense parasite. “Acquiring the research assets from…

Continue Reading

TuesdayOct 31, 2023 10:50 am

NetworkNewsBreaks – GEMXX Corporation (GEMZ) Reports on Key Milestones for 2023, Provides Update on Targets Moving Forward

GEMXX (OTC: GEMZ), a leader in the ammolite gemstone mine-to-market segment and a partner in Canadian gold-exploration company Crazy Horse Mining Inc. (“CHMI”), has released an update on corporate highlights and milestones for the company. According to the announcement, the report is provided for new and existing investors as the company prepares to release its quarter-end financial report. Highlights for this year include the successful completion of the third and final clean-out and recording of gold production at the Snow Creek Mine site for the 2023 mining test season; the partnership with Aurora Geosciences to complete S-K 1300 technical reports…

Continue Reading

MondayOct 30, 2023 3:07 pm

NetworkNewsBreaks – Electronic Servitor Publication Network Inc. (XESP) Announces Participation at Emerging Growth Conference

Electronic Servitor Publication Network (OTCQB: XESP), a digital engagement company and market disruptor, today announced that it has been invited to present at the Emerging Growth Conference on Nov. 1, 2023. The live, interactive online event offers existing shareholders and the investment community an opportunity to interact with the company’s president and CEO Peter Hager. Hager will provide a presentation beginning at 11:25 a.m. ET on Wednesday, Nov. 1, and may subsequently open the floor for questions. Interested parties should visit https://nnw.fm/tRLSI to register for and access the webcast. An archived webcast will be made available on EmergingGrowth.com and on…

Continue Reading

MondayOct 30, 2023 12:47 pm

NetworkNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Extends Collaboration with Romanian Government on Pivotal EM Initiative

SuperCom Ltd. (NASDAQ: SPCB), a global provider of secured solutions for the e-Government, IoT and cybersecurity sectors, today announced, together with its local partner, the receipt of a third order by Romania’s Ministry of Interior, further extending the successful partnership and reinforcing their commitment to Romania’s National Electronic Monitoring (“EM”) Project. According to the announcement, the order is valued at approximately $3.4 million and is anticipated to be delivered by the end of the fourth quarter of 2023. “We are excited to extend our collaboration with the Romanian government on this pivotal initiative. The recent order, valued at $3.4 million,…

Continue Reading

MondayOct 30, 2023 12:21 pm

NetworkNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Reports on 1-for-17 Reverse Stock Split

PaxMedica (NASDAQ: PXMD), a clinical-stage biopharmaceutical company focusing on the development of novel anti-purinergic drug therapies (“APT”) for the treatment of autism spectrum disorder (“ASD”) and other serious conditions with intractable neurologic symptoms, has released information regarding its 1-for-17 reverse stock split. According to the announcement, as a result of the reverse stock split of PaxMedica’s common stock that became effective at 8:03 a.m. ET today, the company’s common stock will begin trading on a split-adjusted basis tomorrow, Oct. 31, 2023, when the market opens. The company noted that its common stock will continue to trade under the existing trading symbol PXMD.…

Continue Reading

MondayOct 30, 2023 12:09 pm

NetworkNewsBreaks – Resourcing Tomorrow Announces Inaugural Roundtable, Reception to Focus on Critical Mineral Strategies

Resourcing Tomorrow, Europe's largest mining event, has announced plans to hold its first Critical Minerals Ministerial Roundtable and Reception next month, in conjunction with the Critical Minerals Association and hosted by the UK All-Party Parliamentary Groups (“APPG”). According to the announcement, representatives from numerous countries will be attending, including Australia, Armenia, Canada, Chad, Nigeria, the Kingdom of Saudi Arabia, the Kyrgyz Republic, the Czech Republic, Portugal, the United Kingdom and the United States. The Resourcing Tomorrow event is slated for Nov. 28–30, 2023, with the roundtable and reception scheduled on Nov. 27, one day before the main event kicks off. According to the announcement, the…

Continue Reading

MondayOct 30, 2023 11:32 am

NetworkNewsBreaks – Safety Shot Inc. (NASDAQ: SHOT) Announces Planned Launch of Its Highly Anticipated Wellness Beverage

Safety Shot (NASDAQ: SHOT) today announced the upcoming direct-to-consumer launch of Safety Shot, the first patented beverage on Earth that helps people feel better faster by reducing blood alcohol content and boosting clarity. Beginning the first week of December 2023, the beverage will be available for retail purchase at www.DrinkSafetyShot.com and www.Amazon.com. In addition, the company plans to launch business-to-business sales of Safety Shot to distributors, retailers, restaurants and bars in the first quarter of 2024. “We’re very excited to launch Safety Shot through our multichannel strategy designed to dominate e-commerce, quickly win retail shelf space, and establish longstanding ties…

Continue Reading

MondayOct 30, 2023 10:42 am

NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces Participation at BIO-Europe Munich 2023

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative inflammation and immunology (“I&I”) biological products primarily for the treatment of autoimmune and infectious diseases, will be attending and participating in BIO-Europe, one of Europe’s premier pharmaceutical industry partnering events. The event is slated for Nov. 6­–8, 2023, in Munich, Germany. According to the announcement, Scinai will showcase both its CDMO services, marketed under the brand Scinai Bioservices, and its in-house nanosized VHH antibody-based therapeutics pipeline. In addition, management will be available to meet with potential partners and clients. Scinai offers a state-of-the-art manufacturing facility for biopharmaceutical…

Continue Reading

FridayOct 27, 2023 2:45 pm

NetworkNewsBreaks – Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) (FSE: A0I0) Completes High-Definition Survey over PCH Ionic Clay Target IV Project Area

Appia (CSE: API) (OTCQX: APAAF) (FSE: A0I0) today announced that it has completed a high-definition lidar and orthophoto survey across an area of 1,702.50 hectares, which includes the company’s priority Ionic Clay Target IV project area in Goias, Brazil. Metro Cúbico Engenharia LTDA, which is headquartered in São Paulo and made up of a multidisciplinary team of professionals with more than 20 years of experience in various technological areas, was engaged by Appia to complete the survey. “Orthophotos are essential for the efficient management of our drill campaign as they provide high-resolution and accurate visual information with maximum detail,” said…

Continue Reading

FridayOct 27, 2023 11:45 am

NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Secures $5.2M in Private Placement and Preferred Investment Option Offerings

InMed Pharmaceuticals (NASDAQ: INM) is a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs. The company today announced that it has closed its offering for the issuance and sale of 3,012,049 pre-funded warrants and preferred investment options to purchase up to an aggregate of 3,012,049 common shares, at a purchase price of $0.83 per pre-funded and associated preferred investment option, in a private placement priced at-the-market under Nasdaq rules. Per a previously announced definitive agreement with respect to certain of its outstanding preferred investment options issued in November 2022 and exercisable for 3,272,733…

Continue Reading